AC Immune(ACIU) - 2024 Q4 - Annual Report

ANNUAL REPORT 2024 Our goal is global leadership in Precision Medicine for the diagnosis and treatment of neurodegenerative diseases we are executing a clear business strategy built on three pillars: alzheimer's disease accelerate development of novel therapeutics in ad with our partners parkinson's and neuro orphans expand our strategic focus in parkinson's disease (pd) and non-ad neurodegenerative diseases, including neuroorphan indications and limbic-predominant age-related tdp-43 encephalopathy (late) d ...